Kounis syndrome: Difference between revisions

Line 23: Line 23:


==Management==
==Management==
 
*Primary treatment should focus on cessation of the [[Anaphylaxis#Management|anaphylactic or allergic event]]


==Disposition==
==Disposition==

Revision as of 06:03, 16 May 2022

Background

Acute coronary syndromes associated with mast cell activation (anaphylaxis or anaphylactoid reaction). Also known as Coronary hypersensitivity disorder.[1]

Clinical Features

  • Stent thrombosis is the main manifestation of Kounis syndrome due to the mast cell infiltration of areas protected by drug-eluting stents[2]
  • ECG changes will correlate with the anatomical region of ischemia

Differential Diagnosis

Chest pain

Critical

Emergent

Nonemergent

Elevated Troponin

True Positive

False (Non-CAD) Positives

Evaluation

Intensity of treatment should be based on ACS likelihood

Workup

Diagnosis

Management

Disposition

See Also

External Links

References

  1. Kounis N. Coronary hypersensitivity disorder: The Kounis syndrome. Clin Ther. 2013 May;35(5):563-71
  2. Kounis NG. Kounis syndrome should be considered the culprit cause of the most feared stent thrombosis. J Am Coll Cardiol. 2011;58:885.